Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.2.30 (
PARP
)
13,611
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In previous works, we found that
PTH
promotes the apoptosis of human Caco-2 intestinal cells, through the mitochondrial pathway. This study was conducted to investigate the modulation of different players implicated in the AKT survival pathway in
PTH
-induced intestinal cell apoptosis. We demonstrate, for the first time, that
PTH
modulates AKT phosphorylation in response to apoptosis via the serine/threonine phosphatase PP2A.
PTH
treatment induces an association of AKT with the catalytic subunit of PP2A and increases its phosphatase activity.
PTH
also promotes the translocation of PP2Ac from the cytosol to the mitochondria. Furthermore, our results suggest that PP2A plays a role in hormone-dependent Caco-2 cells viability and in the cleavage of caspase-3 and its substrate
PARP
. The cAMP pathway also contributes to
PTH
-mediated AKT dephosphorylation while PKC and p38 MAPK do not participate in this event. Finally, we show that
PTH
induces the dissociation between 14-3-3 and AKT, but the significance of this response remains unknown. In correlation with
PTH
-induced Bad dephosphorylation, the hormone also decreases the basal association of 14-3-3 and Bad. Overall, our data suggest that in Caco-2 cells, PP2A and the cAMP pathway act in concert to inactivate the AKT survival pathway in
PTH
-induced intestinal cell apoptosis.
...
PMID:PTH inactivates the AKT survival pathway in the colonic cell line Caco-2. 2000 8